Toshihiko Matsumoto

TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study

Yasutoshi Kuboki, Tomohiro Nishina, Eiji Shinozaki et al. · The Lancet Oncology · 2017 · 171 citations

Phase 1/2, Gastrointestinal Oncology, Medicine +6

Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study)

Hironaga Satake, Takeshi Kato, Koji Oba et al. · The Oncologist · 2020 · 61 citations · Full text

Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients

Hideomi Yamashita, Keiichi Jingu, Yuzuru Niibe et al. · Radiation Oncology · 2017 · 41 citations · Full text

Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study

Keiichi Jingu, Yuzuru Niibe, Hideomi Yamashita et al. · Radiation Oncology · 2017 · 27 citations · Full text

Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan

Tatsuki Ikoma, Mototsugu Shimokawa, Masahito Kotaka et al. · BMC Cancer · 2021 · 25 citations · Full text